Posted by shellson2 on 6th of Feb 2025 at 10:29 am
SEMR--discovered this company. very interesting.
Semrush Holdings, Inc. develops an online visibility management
software-as-a-service platform in the United States, the United
Kingdom, and internationally. The company enables companies to
identify and reach the right audience for their content through the
right channels. Its platform enables the company's customers to
understand trends and act upon insights to enhance the online
visibility, and drive traffic to their websites and social media
pages, as well as online listings, distribute targeted content to
their customers, and measure the digital marketing campaigns.
Posted by shellson2 on 6th of Feb 2025 at 09:42 am
"We believe these data provide further validation of the
RaniPill
®oral delivery platform across a wide variety of
injectable obesity treatments. We are encouraged to see that
delivery of semaglutide via the RaniPill
®capsule demonstrated comparable bioavailability,
pharmacokinetics and weight loss to subcutaneous administration of
semaglutide at the same dose," said Talat Imran, Chief Executive
Officer of Rani Therapeutics. "The target product profile of
semaglutide in the RaniPill
®capsule would be once-weekly oral administration of
semaglutide therapy, which we believe may be more convenient for
patients and could lead to improved adherence. Overall, the
totality of the preclinical data we have generated in the obesity
space demonstrating the successful delivery of both single and
triagonist incretin therapies gives us confidence to continue
building our obesity portfolio to unlock the true value of the
RaniPill
®technology. Looking ahead, we are excited to begin our
Phase 1 study for RT-114, Rani's GLP-1/GLP-2 dual agonist in
partnership with ProGen this year."
Posted by shellson2 on 6th of Feb 2025 at 09:38 am
RANI--very early stages for this company, but successful Phase 1
trial on Semeglatute in pill form. Considered the next holy grail
format to weight loss. Again, a few years away in all
likelihood.
Posted by shellson2 on 4th of Feb 2025 at 08:53 am
HUBC--for the very speculative trader. 32mm Cap, minimal sales.
The stock is approaching $1--(important for nasdaq listing
requirements, etc.). Encourage members to read more about them and
the niche they play within the cyber security field.
The community is delayed by three days for non registered users.
Now on 1st page of
RANI--very early stages for this company, but successful Phase 1 ...
Posted by shellson2 on 6th of Feb 2025 at 10:42 am
Now on 1st page of my FInViz screener
SEMR--discovered this company. very interesting. Semrush
Posted by shellson2 on 6th of Feb 2025 at 10:29 am
SEMR--discovered this company. very interesting.
Semrush Holdings, Inc. develops an online visibility management software-as-a-service platform in the United States, the United Kingdom, and internationally. The company enables companies to identify and reach the right audience for their content through the right channels. Its platform enables the company's customers to understand trends and act upon insights to enhance the online visibility, and drive traffic to their websites and social media pages, as well as online listings, distribute targeted content to their customers, and measure the digital marketing campaigns.
HAIN--my "RFK Jr get approved
Posted by shellson2 on 6th of Feb 2025 at 10:11 am
HAIN--my "RFK Jr get approved healthy food play" . Been crushed over past year+, may be due for a bounce back?
"We believe these data provide
RANI--very early stages for this company, but successful Phase 1 ...
Posted by shellson2 on 6th of Feb 2025 at 09:42 am
"We believe these data provide further validation of the RaniPill ®oral delivery platform across a wide variety of injectable obesity treatments. We are encouraged to see that delivery of semaglutide via the RaniPill ®capsule demonstrated comparable bioavailability, pharmacokinetics and weight loss to subcutaneous administration of semaglutide at the same dose," said Talat Imran, Chief Executive Officer of Rani Therapeutics. "The target product profile of semaglutide in the RaniPill ®capsule would be once-weekly oral administration of semaglutide therapy, which we believe may be more convenient for patients and could lead to improved adherence. Overall, the totality of the preclinical data we have generated in the obesity space demonstrating the successful delivery of both single and triagonist incretin therapies gives us confidence to continue building our obesity portfolio to unlock the true value of the RaniPill ®technology. Looking ahead, we are excited to begin our Phase 1 study for RT-114, Rani's GLP-1/GLP-2 dual agonist in partnership with ProGen this year."
RANI--very early stages for this
Posted by shellson2 on 6th of Feb 2025 at 09:38 am
RANI--very early stages for this company, but successful Phase 1 trial on Semeglatute in pill form. Considered the next holy grail format to weight loss. Again, a few years away in all likelihood.
Thx. More lift after hours.
ATOM, CRNC & BBAI held nice at close
Posted by shellson2 on 5th of Feb 2025 at 08:26 pm
Thx. More lift after hours. Serious mojo
Analysts (some at least), call
ATOM, CRNC & BBAI held nice at close
Posted by shellson2 on 5th of Feb 2025 at 10:17 am
Analysts (some at least), call this a baby Plantir (I'm para-phrasing), but you get the idea...
Now up 25%
BBAI
ATOM, CRNC & BBAI held nice at close
Posted by shellson2 on 5th of Feb 2025 at 09:23 am
BBAI
Moving again this morning
ATOM, CRNC & BBAI held nice at close
Posted by shellson2 on 5th of Feb 2025 at 09:23 am
Moving again this morning
PTCT--repost from Matt on 5/1. Cantor
PTCT follow up - nice move
Posted by shellson2 on 4th of Feb 2025 at 01:14 pm
PTCT--repost from Matt on 5/1.
Cantor slaps $117 price target, upped from $79. FWIW
Continues to be a great
BFLY--heavy volume, up 9%
Posted by shellson2 on 4th of Feb 2025 at 12:27 pm
Continues to be a great call master. Strong again today
Clawing its way back...
BRBR reporting today - still holding up (no position for ...
Posted by shellson2 on 4th of Feb 2025 at 11:56 am
Clawing its way back...
BBAi--really moving today (halo effect
ATOM, CRNC & BBAI held nice at close
Posted by shellson2 on 4th of Feb 2025 at 10:48 am
BBAi--really moving today (halo effect from palantir)
BRBR--results were better than expected,
BRBR reporting today - still holding up (no position for ...
Posted by shellson2 on 4th of Feb 2025 at 10:47 am
BRBR--results were better than expected, but its selling off. Has had a good run. Monitoring
Thx
FUBO RDDT
Posted by shellson2 on 4th of Feb 2025 at 10:45 am
Thx
Up 30%, very strong Vol.
HUBC--for the very speculative trader. 32mm Cap, minimal sales. The ...
Posted by shellson2 on 4th of Feb 2025 at 09:54 am
Up 30%, very strong Vol.
Steve--OSS on the move...
Posted by shellson2 on 4th of Feb 2025 at 09:51 am
Steve--OSS on the move...
HUBC--for the very speculative trader.
Posted by shellson2 on 4th of Feb 2025 at 08:53 am
HUBC--for the very speculative trader. 32mm Cap, minimal sales. The stock is approaching $1--(important for nasdaq listing requirements, etc.). Encourage members to read more about them and the niche they play within the cyber security field.
FTNT—reports tomorrow AH’s (expected). I
Posted by shellson2 on 4th of Feb 2025 at 08:26 am
FTNT—reports tomorrow AH’s (expected). I like the set up. Strong chart.
Pause in place for Canada.
Both sides likely waiting for Canada headline for next move, ...
Posted by shellson2 on 3rd of Feb 2025 at 04:48 pm
Pause in place for Canada. GM up 2.6%